Kite Pharma, Inc.: cashflow_operating
| Value | {"amount": -17072000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-12-31 |
| Status | current |
| Entity | Kite Pharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bd9addcf-7924-443d-8d46-b483d90fec80
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001510580-17-000003 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510580/cashflow-operating/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bd9addcf-7924-443d-8d46-b483d90fec80
History
- supersedes {"amount": -17072000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001564590-15-001985)